Decreased contractility and norepinephrine content of guinea-pig seminal vesicles after chronic treatment with testosterone.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001464:Barium / Q000494:pharmacology; D002395:Catecholamines / Q000032:analysis; D002712:Chlorides / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000032:analysis / Q000494:pharmacology; D005837:Genitalia, Male / Q000032:analysis; D006168:Guinea Pigs; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D008854:Microscopy, Electron; D009119:Muscle Contraction / Q000187:drug effects*; D009638:Norepinephrine / Q000032:analysis* / Q000494:pharmacology; D012669:Seminal Vesicles / Q000032:analysis / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D013050:Spectrometry, Fluorescence; D013739:Testosterone / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology
D002395:Catecholamines; D002712:Chlorides; D000804:Angiotensin II; D001464:Barium; D013739:Testosterone; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine